Zobrazeno 1 - 6
of 6
pro vyhledávání: '"M. L. Tornesello"'
Publikováno v:
Infectious Agents and Cancer, Vol 13, Iss 1, Pp 1-5 (2018)
Abstract Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and accounts for about 6% of all new cancers diagnosed worldwide. Moreover, it is the third and the fifth leading cause of death from cancer in men and women, respect
Externí odkaz:
https://doaj.org/article/e8098759d95c4915a0ba78fee80ae7de
Publikováno v:
Tissue antigens. 81(1)
The newly detected HLA-B*51:141 is distinguished from HLA-B*51:08 by a single-nucleotide exchange at codon 30 where D is replaced by Y.
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 56:66
Publikováno v:
Intervirology. 36(2)
To investigate the possible direct/indirect role of Human immunodeficiency virus (HIV) as a cofactor in human papillomavirus (HPV) oncogenesis, cotransfection experiments were carried out in which a recombinant plasmid containing the HPV16 long contr
Autor:
L. Buonaguro, D. Greco, M. L. Tornesello, M. Rago, M. Zacarelli, F. Curcio, G. Castello, N. Sguazzo, G. Pipolo, E. BethGiraldo, F. M. Buonaguro, G. Giraldo
Publikováno v:
AIDS. 8:268
Autor:
Daniela Marasco, Luigi Buonaguro, Franco M. Buonaguro, Maria Lina Tornesello, Angelo De Stradis, Maxim Totrov, Maria Tagliamonte, Alessia Ruggiero
Publikováno v:
PLoS ONE
PLoS ONE; Vol 7
11th NATIONAL CONGRESS OF THE ITALIAN SOCIETY FOR VIROLOGY, pp. 37–37, ORVIETO, September 17-19, 2012
info:cnr-pdr/source/autori:Tagliamonte M., Marasco D., Ruggiero A., De Stradis A., Tornesello M.L., Totrov M., Buonaguro F.M., Buonaguro L./congresso_nome:11th NATIONAL CONGRESS OF THE ITALIAN SOCIETY FOR VIROLOGY/congresso_luogo:ORVIETO/congresso_data:September 17-19, 2012/anno:2012/pagina_da:37/pagina_a:37/intervallo_pagine:37–37
PLoS ONE, Vol 7, Iss 8, p e43318 (2012)
PloS one 7 (2012): e43318. doi:10.1371/journal.pone.0043318
info:cnr-pdr/source/autori:Tagliamonte M., Marasco D., Ruggiero A., De Stradis A. Tornesello M.L., Totrov M., Buonaguro F.M., Buonaguro L./titolo:HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens/doi:10.1371%2Fjournal.pone.0043318/rivista:PloS one/anno:2012/pagina_da:e43318/pagina_a:/intervallo_pagine:e43318/volume:7
Publons
PLoS ONE; Vol 7
11th NATIONAL CONGRESS OF THE ITALIAN SOCIETY FOR VIROLOGY, pp. 37–37, ORVIETO, September 17-19, 2012
info:cnr-pdr/source/autori:Tagliamonte M., Marasco D., Ruggiero A., De Stradis A., Tornesello M.L., Totrov M., Buonaguro F.M., Buonaguro L./congresso_nome:11th NATIONAL CONGRESS OF THE ITALIAN SOCIETY FOR VIROLOGY/congresso_luogo:ORVIETO/congresso_data:September 17-19, 2012/anno:2012/pagina_da:37/pagina_a:37/intervallo_pagine:37–37
PLoS ONE, Vol 7, Iss 8, p e43318 (2012)
PloS one 7 (2012): e43318. doi:10.1371/journal.pone.0043318
info:cnr-pdr/source/autori:Tagliamonte M., Marasco D., Ruggiero A., De Stradis A. Tornesello M.L., Totrov M., Buonaguro F.M., Buonaguro L./titolo:HIV p24 as Scaffold for Presenting Conformational HIV Env Antigens/doi:10.1371%2Fjournal.pone.0043318/rivista:PloS one/anno:2012/pagina_da:e43318/pagina_a:/intervallo_pagine:e43318/volume:7
Publons
Heterologous protein scaffolds engrafted with structurally defined HIV Env epitopes recognized by broadly neutralizing monoclonal antibodies (MAbs) represent a promising strategy to elicit broad neutralizing antibodies. In such regards, a protein sca